Although SALL4 is rarely mutated (0.1%) in GC, analysis of the TCGA pan-cancer dataset revealed that SALL4 is amplified in GC and other human cancers, including lung squamous cell carcinoma, colon carcinoma, bladder carcinoma, and lung adenocarcinoma (Figure 4C). The gene discussed is SALL4; the disease is gastric cancer.